These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32523435)

  • 1. The argument of the ORBITA study: angioplasty is useless.
    Bolognese L
    Eur Heart J Suppl; 2020 Jun; 22(Suppl E):E34-E36. PubMed ID: 32523435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ORBITA trial: A point of view.
    Oliveira VD; Giugni FR; Martins EB; Azevedo DFC; Lima EG; Serrano Júnior CV
    Rev Assoc Med Bras (1992); 2018 Feb; 64(2):100-103. PubMed ID: 29641663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ORBITA: What Goes Around, Comes Around… Or Does It?
    Jackson M; Zaman A
    Interv Cardiol; 2018 Sep; 13(3):135-136. PubMed ID: 30443270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Percutaneous coronary intervention in stable angina pectoris : Objective randomised blinded investigation with optimal medical therapy of angioplasty in stable angina (ORBITA) trial].
    Kugler C; Wöhrle J; Nitschmann S
    Internist (Berl); 2018 Sep; 59(9):993-996. PubMed ID: 30073442
    [No Abstract]   [Full Text] [Related]  

  • 5. Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina.
    Schueler R; Al-Lamee R; Mahfoud F; Capodanno D; Al Asnag M; Haude M
    EuroIntervention; 2018 Oct; 14(8):951-954. PubMed ID: 30175964
    [No Abstract]   [Full Text] [Related]  

  • 6. Rethinking revascularization in patients with stable angina.
    Harskamp RE; Park DW
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):159-161. PubMed ID: 29338462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term prognosis in patients with single-vessel or double-vessel coronary artery disease: does successful revascularization achieved by coronary angioplasty improve late outcome?].
    Kawaharada T
    J Cardiol; 2003 Jul; 42(1):1-11. PubMed ID: 12892036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA) and coronary stents: A case study in the analysis and reporting of clinical trials.
    Gelman A; Carlin JB; Nallamothu BK
    Am Heart J; 2019 Aug; 214():54-59. PubMed ID: 31163269
    [No Abstract]   [Full Text] [Related]  

  • 9. Is it possible that angioplasty does not improve the quality of life in patients with stable angina?
    Golino P
    Eur Heart J Suppl; 2022 Nov; 24(Suppl I):I100-I103. PubMed ID: 36380778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
    Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
    N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses.
    Hueb WA; Bellotti G; de Oliveira SA; Arie S; de Albuquerque CP; Jatene AD; Pileggi F
    J Am Coll Cardiol; 1995 Dec; 26(7):1600-5. PubMed ID: 7594092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989.
    Wong JB; Sonnenberg FA; Salem DN; Pauker SG
    Ann Intern Med; 1990 Dec; 113(11):852-71. PubMed ID: 2146912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME InvestigatorS.
    Folland ED; Hartigan PM; Parisi AF
    J Am Coll Cardiol; 1997 Jun; 29(7):1505-11. PubMed ID: 9180111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte.
    Zeymer U; Uebis R; Vogt A; Glunz HG; Vöhringer HF; Harmjanz D; Neuhaus KL;
    Circulation; 2003 Sep; 108(11):1324-8. PubMed ID: 12939210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous transluminal coronary angioplasty and the changing indications for coronary artery bypass grafting for single-vessel coronary artery disease.
    Simari RD; Bell MR; Schaff HV; Holmes DR
    Mayo Clin Proc; 1992 Apr; 67(4):317-22. PubMed ID: 1548945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.
    Wilson JM; Ferguson JJ
    Tex Heart Inst J; 1995; 22(2):145-61. PubMed ID: 7647598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revascularization interventions for ischemic heart disease.
    Moustapha A; Anderson HV
    Curr Opin Cardiol; 2000 Nov; 15(6):463-71. PubMed ID: 11198628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.